• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    InCarda Therapeutics Announces RESTORE-1 Ph 3 Trial Results

    30 Sep 2024 //

    BUSINESSWIRE

    InCarda terminates its PhIII trial for arrhythmia drug

    13 Jun 2023 //

    ENDPTS

    InCarda, PhysIQ and Syneos team for phase 3 flecainide study

    31 Aug 2022 //

    FIERCEBIOTECH

    physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

    24 Aug 2022 //

    BUSINESSWIRE

    InCarda Therapeutics Provides Corporate Update

    10 Jun 2021 //

    BIOSPACE

    InCarda Therapeutics Provided Corporate Update

    09 Jun 2021 //

    GLOBENEWSWIRE

    InCarda unrolls mid-stage data backing inhaled arrhythmia drug

    09 Jun 2021 //

    ENDPTS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.